KYORIN Pharmaceutical Market Cap

KYORIN Pharmaceutical has a market cap or net worth of 87.51 billion as of July 30, 2025. Its market cap has decreased by -9.92% in one year.

Market Cap

87.51B

Enterprise Value

99.43B

Revenue

130.09B

Ranking

n/a

PE Ratio

9.63

Stock Price

1,528.00

Market Cap Chart

Since March 10, 2006, KYORIN Pharmaceutical's market cap has increased from 18.24B to 87.51B, an increase of 379.63%. That is a compound annual growth rate of 8.42%.

Market Cap History

Date	Market Cap	% Change
Jul 29, 2025	87.62B	1.34%
Dec 30, 2024	86.46B	-15.45%
Dec 29, 2023	102.26B	3.75%
Dec 30, 2022	98.56B	-6.82%
Dec 30, 2021	105.78B	-4.89%
Dec 30, 2020	111.22B	1.70%
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Dec 30, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Chugai Pharmaceutical	12.23T
Takeda Pharmaceutical Company	6,832.80B
Daiichi Sankyo Company	6,761.19B
HOYA Corporation	6,627.23B
Terumo	3,820.12B
Otsuka Holdings	3,701.64B
Astellas Pharma	2,667.56B
Shionogi &	2,172.66B

Market Cap Rankings